We're on a mission to help provide resources, education, support and access to the safest, most effective and competitively priced cannabis-based wellness products for consumers in emerging and underserved markets.
Led by some of the industry's leading physicians, we strive to supply the highest-quality CBD products available through a diverse group of collaborative partners.
Our goal is to offer consumers a wide range of physician-approved resources and CBD products that can meet any individual’s needs — without being limited to any single brand or product type.
Following his residency and fellowship training, Dr. Doner received extensive post-doctoral training in medical cannabis and has treated thousands of patients as medical cannabis has expanded in the United States. In addition to his clinical work, Dr. Doner is also heavily involved in clinical research, and serves as primary and sub-investigator on numerous past and current clinical trials.
Doner has been a featured speaker and panel member at numerous medical cannabis events and educational seminars, both in the United States and abroad. He has also been featured on numerous media outlets, including Medical Marijuana Minutes with The Cannabis Reporter, and currently serves on numerous medical cannabis industry advisory boards and panels.
Dr. Doner is a member of the American Osteopathic Association, American Academy of Cannabinoid Medicine, Americans for Safe Access, and the Society of Cannabis Clinicians.
We're bringing together a group of core competencies that are unique to the medical cannabis industry.
Initiated and led by expert physicians, AWG was created, and our platform developed, based on years of experience in the medical cannabis, pharmaceutical, clinical research, and consumer product industries.
We are committed to the development of medical cannabis, and its related products, that supports not only healthy alternatives for consumers, but that can also serve to help build the required infrastructure and education in developing regions and markets to be successful long-term, and without international reliance.
Our staff has been part of product development, clinical research and support, and regulatory guidance in the medical cannabis industry with years of first-hand experience. In a new and developing industry such as medical cannabis, this knowledge and understanding can only be developed over time and with commitment, and we at AWG feel that our experience provides the foundation for which we build our success.